Zhuang Z, Gnarra J R, Dudley C F, Zbar B, Linehan W M, Lubensky I A
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Mod Pathol. 1996 Aug;9(8):838-42.
The von Hippel-Lindau (VHL) disease gene on chromosome 3p25.5 has been cloned and shown to be mutated in the germline DNA of patients with VHL disease. In addition, approximately 60% of sporadic renal cell carcinomas (RCCs) have been shown to have a VHL gene mutation in fresh frozen tumor tissue and tumor-derived cell lines. The objective of this study was to test whether VHL gene mutations could be detected in archival sporadic RCC cases. We studied three sporadic RCCs, two oncocytomas, and the corresponding adjacent normal renal parenchyma by polymerase chain reaction and single-strand conformation polymorphism analysis using paraffin-embedded, formalin-fixed material. Tumor and normal tissue were microdissected from eosin-stained 5-microns-thick histologic sections. Mutations in exon 2 of the VHL gene were detected in all three of the sporadic RCCs but were not observed in the matched normal renal tissues or in the two oncocytomas tested. The mutations were identical to those detected in tumor cell lines from the same patients. This report represents the first detection of VHL gene mutations in sporadic RCCs in archival, paraffin-embedded tissue. A high percentage of sporadic RCCs show VHL gene mutations in fresh frozen tissue but the availability of frozen material is limited, so the evaluation of archival tumors for similar mutations should prove useful in future RCC studies. Furthermore, the results suggest that the genetic events leading to the development of clinically benign renal oncocytoma may differ from those leading to malignant RCC.
位于3号染色体p25.5区域的冯·希佩尔-林道(VHL)病基因已被克隆,并显示在VHL病患者的生殖系DNA中发生了突变。此外,大约60%的散发性肾细胞癌(RCC)在新鲜冷冻的肿瘤组织和肿瘤衍生细胞系中已被证明存在VHL基因突变。本研究的目的是检测在存档的散发性RCC病例中是否能检测到VHL基因突变。我们使用石蜡包埋、福尔马林固定的材料,通过聚合酶链反应和单链构象多态性分析,研究了3例散发性RCC、2例嗜酸细胞瘤以及相应的相邻正常肾实质。从5微米厚的嗜伊红染色组织切片中显微切割肿瘤和正常组织。在所有3例散发性RCC中均检测到VHL基因第2外显子的突变,但在匹配的正常肾组织或所检测的2例嗜酸细胞瘤中未观察到突变。这些突变与同一患者肿瘤细胞系中检测到的突变相同。本报告首次在存档的石蜡包埋组织中的散发性RCC中检测到VHL基因突变。高比例的散发性RCC在新鲜冷冻组织中显示VHL基因突变,但冷冻材料的可用性有限,因此对存档肿瘤进行类似突变的评估在未来RCC研究中应会被证明是有用的。此外,结果表明导致临床良性肾嗜酸细胞瘤发生的遗传事件可能与导致恶性RCC的遗传事件不同。